Castle Biosciences
CSTL
CSTL
160 hedge funds and large institutions have $988M invested in Castle Biosciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 72 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4.96% more ownership
Funds ownership: 84.8% → 89.76% (+5%)
1% more funds holding
Funds holding: 159 → 160 (+1)
Holders
160
Holding in Top 10
2
Calls
$480K
Puts
$8K
Top Buyers
| 1 | +$27.3M | |
| 2 | +$14.7M | |
| 3 | +$10.4M | |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$9.53M |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$9.25M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.8M | |
| 3 | -$4.9M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$4.73M |
| 5 |
RI
RTW Investments
New York
|
-$4.59M |